Trial · NCT07907120
Cost-Effectiveness of Upfront Supplemental Anaesthesia in Symptomatic Irreversible Pulpitis
NCT07907120, Phase 4, Not yet recruiting, Jamia Millia Islamia
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Cost-Effectiveness of Upfront Supplemental Anaesthesia in Symptomatic Irreversible Pulpitis. Trials, record NCT07907120. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07907120
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Cost-Effectiveness of Upfront Supplemental Anaesthesia in Symptomatic Irreversible Pulpitis
- NCT number
- NCT07907120
- Status
- Not yet recruiting
- Phases
- Phase 4
- Enrollment
- 234 participants, estimated
- Lead sponsor
- Jamia Millia Islamia
- Conditions
- Irreversible Pulpitis, Anesthesia, Local
- Interventions
Inferior Alveolar Nerve Block With 2% Lidocaine With 1:80,000 Adrenaline, Upfront Buccal Infiltration With 4% Articaine With 1:100,000 Adrenaline, Upfront Intraligamentary Injection With 2% Lidocaine With 1:80,000 Adrenaline, Standardised Stepwise Rescue Anaesthesia Ladder
- First posted
- 2026-10-30
- Last updated
- 2026-10-30
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Initial-Strategy Anaesthetic Success | Perioperative | Proportion of participants in whom access cavity preparation, pulp extirpation and canal instrumentation are completed with no or mild pain (Heft-Parker visual analogue scale \[HP VAS\] 54 mm or less on the 170-mm scale, where 0 = no pain and 170 = worst pain) and without any rescue injection. |
| Primary | Incremental Cost-Effectiveness Ratio (Public-Provider Perspective) | Day 1 | Difference in mean cost per patient divided by the difference in proportion of initial-strategy success, for Arm B vs Arm A and Arm C vs Arm A. Costs are micro-costed per patient (dentist and assistant time, cartridges, needles, equipment, overheads and rebooked visits) in Indian rupees at 2026 prices using public-sector unit costs. Reported as INR per additional initial-strategy success, with net monetary benefit across willingness-to-pay values of INR 0 to 2,000 per additional success. |
| Secondary | Anaesthetic Chair Time | Perioperative | Minutes from the start of the first injection to the end of canal instrumentation (or session abandonment), recorded by an independent time-motion observer. |
| Secondary | Total Visit Time | Perioperative | Minutes from the patient being seated to leaving the chair, summed across the index visit and any rebooked visit for the same tooth, recorded by an independent time-motion observer. |
| Secondary | Number of Injections and Anaesthetic Cartridges Used | Perioperative | Count per participant of injections (by type) and local anaesthetic cartridges (by drug), including repeat IANB and rescue injections. |
| Secondary | Number of Rescue Steps | Perioperative | Number and type of rescue steps of the standardised rescue ladder required per participant. |
| Secondary | Patient satisfaction | Day 1 | 5-Point Likert scale will be used |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 22414822 | BACKGROUND |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07907120
GET https://conductscience.org/api/trials/v1/NCT07907120/registered